HOME >> BIOLOGY >> NEWS
Cytori demonstrates adipose stem cells improve cardiac function in preclinical heart attack model

San Diego, CA, October 17, 2005 - Cytori Therapeutics, Inc. (Frankfurt: XMP), today presented results demonstrating that adipose stem cells improved cardiac function following a severe heart attack in a porcine study. This is the first preclinical study in which the injected cells were autologous, meaning they came from the animals' own tissue, were not cultured, so that they did not undergo multiple cell divisions to achieve a target dose of cells, and were harvested and administered on the day of the heart attack. The results of the study, conducted in collaboration with Tulane University, were presented at the 17th annual Transcatheter Cardiovascular Therapeutics 2005 conference in Washington, D.C. (abstract no. 158).

In this randomized study, 17 animals received either injections of their own adipose stem and regenerative cells (treated) or a saline injection (control) via catheter into the artery at the site of the heart attack. After eight weeks, there was a statistically significant reduction in the perfusion defect, which is the area of the heart deprived of oxygen as a result of the infarct. A corresponding benefit was observed by the improvement in ejection fraction, a common measure of the heart's pumping efficiency.

"Our study was unique in that the animals received an injection of autologous cells that were not cultured and administered immediately following a heart attack," said Marc H. Hedrick, M.D., President for Cytori Therapeutics. "Additionally, it shows that a sufficient number of cells could be accessed from adipose tissue in real-time to achieve a therapeutic effect, which closely approximates a clinical setting where timely delivery may be critical. These data confirm our previous results and will serve as an important component of our forthcoming application to initiate European clinical studies next year."

Adipose tissue, also known as fat, is an abundant source of stem cells and other regenerative cells that can
'"/>


17-Oct-2005


Page: 1 2

Related biology news :

1. New study demonstrates important role of glia in circadian timing
2. Stowers Institutes Workman Lab demonstrates mechanism for decoding histone modification marks
3. BEMA Fentanyl demonstrates substantial transmucosal delivery
4. Xie Lab demonstrates the role of microRNA pathway
5. Rong Li Lab demonstrates the process of mammalian egg maturation
6. Compelling evidence demonstrates that Hobbit fossil does not represent a new species of hominid
7. OHSU research demonstrates possible health risks for children born to overeating mothers
8. New research demonstrates bone-marrow derived stem cells can reverse genetic kidney disease
9. NYUS Childress demonstrates tool for studying hovering flight at international science meeting
10. Study demonstrates rapid diagnosis of urinary tract infections with biosensor technology
11. Report demonstrates safety of nuclear medicine procedures

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... , ... August 25, 2020 ... ... biotechnology company developing novel pharmaceuticals targeting mitochondria, in partnership with Essex Bio-Technology, ... in its pivotal U.S. Phase 3 VISTA-2 study of SkQ1 ophthalmic solution ...
(Date:8/21/2020)... ... 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application ... COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 study ...
(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, based in Basel, ... license agreements with Housey Pharma’s HMI subsidiary to gain access to its core-enabling ... Research and Development spending in excess of US $10 billion. , Scientists at ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Slone Partners , ... announced the placement of Julianne Averill , CPA, as Chief Financial Officer ... operations and implementing key business strategies to accelerate Alveo’s growth as the company ...
(Date:8/15/2020)... ... August 13, 2020 , ... True Terpenes , the leading ... Scientific Advisory Board (SAB) to research the medical potential of terpenes and the potential ... combined with terpenes. The board is focused on expanding the recently launched line of ...
(Date:8/12/2020)... ... August 11, 2020 , ... The FSHD Society announced ... Dystrophy Clinical Trial Research Network (FSHD CTRN), with consideration of follow-on ... consortium of academic research centers in the United States and Europe with expertise ...
(Date:8/12/2020)... Mich. (PRWEB) , ... August 12, 2020 , ... ... Group, Inc. (EMMA International), a global leader in FDA compliance consulting has ... the nation’s fastest-growing private companies. The list represents a unique look at the ...
Breaking Biology Technology:
Cached News: